The main risk associated with active surveillance is the possibility of cancer progression during the monitoring period. If the cancer grows or spreads, it could become more challenging to treat successfully. However, studies indicate that the risk of missing the window for curative treatment is relatively low when active surveillance protocols are followed correctly.
